about
Vaccine development for tuberculosis: current progressFragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays.Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis.Prokaryotic expression and in vitro functional analysis of IL-1β and MCP-1 from guinea pig.Kinetics of IFN-gamma and TNF-alpha gene expression and their relationship with disease progression after infection with Mycobacterium tuberculosis in guinea pigs.Protective efficacy of a recombinant BCG secreting antigen 85B/Rv3425 fusion protein against Mycobacterium tuberculosis infection in mice.Self-adjuvanting bacterial vectors expressing pre-erythrocytic antigens induce sterile protection against malariaAntibody-mediated immunity against tuberculosis: implications for vaccine developmentMucosal vaccination against tuberculosis using inert bioparticles.Elimination of the cold-chain dependence of a nanoemulsion adjuvanted vaccine against tuberculosis by lyophilization.An update on vaccines for tuberculosis - there is more to it than just waning of BCG efficacy with time.Old foes, new challenges: syphilis, cholera and TB.Animal Models for Tuberculosis in Translational and Precision Medicine.A review of clinical models for the evaluation of human TB vaccines.A role for interleukin-17A in modulating intracellular survival of Mycobacterium bovis bacillus Calmette-Guérin in murine macrophages.Prophylactic potential of defensins and L-isoleucine in tuberculosis household contacts: an experimental model.Simultaneous inhibition of T helper 2 and T regulatory cell differentiation by small molecules enhances Bacillus Calmette-Guerin vaccine efficacy against tuberculosis.Method for assessing IFN-γ responses in guinea pigs during TB vaccine trials.Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach.
P2860
Q26827737-0541F556-72A8-4610-930D-5A44FF31068CQ33810047-8099D377-8C70-4B40-A713-59A9B4136F15Q34146613-0F7A486F-C873-44EC-9DB5-5D32664E71D4Q36675666-B0B96EF3-4334-4044-B567-84BCD4E2879EQ36793138-5D8F7BF1-90DF-4299-B113-93BD6E062E14Q36849823-E75B5538-E044-4C48-87D3-8C7DB35C8AAFQ36981626-5E45096B-0328-41D0-B920-AFD37922B454Q37137882-7DE87795-941F-443D-8B5D-36BA93CA941AQ37264883-71F2F495-0309-4F24-B9A3-84FC183C30FEQ37641418-D2C0CE69-5D96-4F2C-811B-4E09589CB61DQ38041566-11D17B4B-04C9-4048-8A04-458D1A33BDD6Q38078460-FB8A5314-279F-4649-9531-20039727529CQ38681974-6396FEB7-845A-463E-BCBF-42CADD1C3206Q38711772-00C199F6-BF14-4DF5-B8FB-53D1F36AB239Q39133864-307EE5D6-E58F-4556-99E8-85AE9F341ACDQ41169862-B7049920-E481-4C58-A31E-A17B2BC2991FQ41880897-E0A62330-D7B4-4448-AEB5-F57868EF0E57Q46493610-BC25E9C5-2D8A-4E68-8A32-34D92CC2CB2CQ47834561-B5FE988C-16F5-4B43-8D39-58080B731768Q55436384-45619387-307D-4D51-A7FD-987EBEACA3F3
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Tuberculosis vaccines: progress and challenges.
@ast
Tuberculosis vaccines: progress and challenges.
@en
type
label
Tuberculosis vaccines: progress and challenges.
@ast
Tuberculosis vaccines: progress and challenges.
@en
prefLabel
Tuberculosis vaccines: progress and challenges.
@ast
Tuberculosis vaccines: progress and challenges.
@en
P1476
Tuberculosis vaccines: progress and challenges.
@en
P2093
Anna M Checkley
P304
P356
10.1016/J.TIPS.2011.06.003
P577
2011-07-29T00:00:00Z